J0882 Darbepoetin alfa, esrd use
Also known as: Aranesp, darbepoetin alfa ESRD, ESA
Darbepoetin alfa injection for patients with end-stage renal disease, an erythropoiesis-stimulating agent for anemia management in dialysis patients.
In Plain Language
Medicine to increase red blood cells in kidney disease
Clinical Context
Used for treatment of anemia in patients with end-stage renal disease on hemodialysis or peritoneal dialysis.
RVU Information
CPT J0882 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J0882?
CPT J0882 (Darbepoetin alfa, esrd use) is a J Codes (Drugs) code. Darbepoetin alfa injection for patients with end-stage renal disease, an erythropoiesis-stimulating agent for anemia management in dialysis patients.
How is J0882 administered?
CPT J0882 is administered by a healthcare provider, typically via injection or infusion. Used for treatment of anemia in patients with end-stage renal disease on hemodialysis or peritoneal dialysis. It is used by Nephrology, Internal Medicine, Dialysis.
When is CPT J0882 used?
Used for treatment of anemia in patients with end-stage renal disease on hemodialysis or peritoneal dialysis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.